Skin cancer deaths higher in men than in women: Study | WeForNews | Latest News, Blogs Skin cancer deaths higher in men than in women: Study – WeForNews | Latest News, Blogs
Connect with us

Health

Skin cancer deaths higher in men than in women: Study

Published

on

cancer

London, Nov 5 : The global death rates for melanoma — most serious type of skin cancer — has seen a steep rise in men since 1985, with mortality rates among women rising more slowly or even declining, according to researchers, including one of Indian-origin.

It could be because men are less likely to protect themselves from the sun or engage with melanoma awareness and prevention campaigns, the researchers noted.

“The major risk factor for melanoma is overexposure to ultraviolet radiation, either from sun exposure or from using sunbeds,” said Dorothy Yang, junior doctor at the Royal Free London NHS Foundation Trust, UK.

“Despite public health efforts to promote awareness of melanoma and encourage sun-smart behaviours, melanoma incidence has been increasing in recent decades,” Yang added.

The results were presented at the NCRI Cancer Conference in Glasgow.

For the study, the team studied death rates in the 33 countries between 1985 and 2015 considering an ageing population and other countries having a younger demographic.

Overall, the highest three-year average death rates for 2013 to 2015 were found in Australia (5.72 per 100,000 men and 2.53 per 100,000 in women) and Slovenia (3.86 in men and 2.58 in women), with the lowest in Japan (0.24 in men and 0.18 in women).

However, the Czech Republic was the only country where the team found a decrease in men’s melanoma death rate, where there was as estimated annual percentage decrease of 0.7 per cent between 1985 and 2015.

In addition, Israel and the Czech Republic experienced the largest decrease in mortality rates in women, — 23.4 per cent and 15.5 per cent respectively.

“This research shows that death rates for melanoma are stabilising or decreasing in some countries, particularly for women, but in almost all countries there was an increase in death rates over the past 30 years in men,” said Poulam Patel, Professor at the University of Nottingham in the UK.

However, more research is needed to understand the reason for this trend, but in the meantime, more public health efforts targeted at men may be needed to raise awareness of the disease and of sun-smart behaviours, the team noted.

Disaster

‘Situation going out of control’: SC seeks Covid report from Delhi, Gujarat, Maharashtra and Assam

A bench headed by Justice Ashok Bhushan said the infections in these states are “going out of control” and asked them to submit a status report within two days.

Published

on

Coronavirus India

The Supreme Court on Monday sought a status report from Delhi, Gujarat, Maharashtra, and Assam on steps taken to control the spread of coronavirus infection, news agency PTI reported. A bench headed by Justice Ashok Bhushan said the infections in these states are “going out of control” and asked them to submit a status report within two days.

“Things have worsened in Delhi especially in November. You file a status report on what steps have been taken,”the court told Additional Solicitor General Sanjay Jain, who was appearing for the Delhi government. The bench, also comprising Justices R S Reddy and M R Shah, said that all efforts shall be made by the Centre and the states to mitigate the situation and to deal with the rising number of COVID-19 cases.

While fresh cases of coronavirus infections continue to decline — or remain stagnant — in the worst-affected states of Maharashtra, Karnataka, and Andhra Pradesh, on the other hand, Haryana, Punjab, Rajasthan, Gujarat, Madhya Pradesh and even Himachal Pradesh have been seeing a significant rise in active cases.

Amid the surge in a few states, the Centre on Sunday dispatched high-level teams to Uttar Pradesh, Punjab and Himachal Pradesh to help them tackle the spread of the disease. A few days ago, similar teams were sent to Rajasthan, Gujarat, Haryana and Chhattisgarh as well.

Part of the reason for the surge in cases in these states could be attributed to low adherence of physical distancing norms during the festival season, especially since it came after a prolonged phase of relative stability, which could have given rise to complacency amongst the public.

On Monday, India’s COVID-19 caseload went past 91 lakh with 44,059 coronavirus infections being reported in a day, while the recoveries surged to 85,62,641. The number of active cases remained below 5 lakh for the thirteenth consecutive day. There are 4,43,486 active cases of coronavirus infection in the country as on date which comprises 4.85 per cent of the total caseload.

Continue Reading

Health

Covid-19: Govt may get Oxford shots in Jan-Feb, at 50% of MRP

The SII has almost completed its phase 3 trials in India and a follow-up of the data is likely to start soon.

Published

on

Vaccine

NEW DELHI: India is likely to get the first lot of anti-Covid shots in late January-early February which will allow some frontline workers like doctors, nurses and municipal staff to get the vaccine. This will be possible as India plans to give Serum Institute of India (SII) emergency use approval for the Oxford-AstraZeneca vaccine candidate soon after it gets similar approval in the UK.

While the SII will need to apply for emergency use, the firm is expected to do so in December. The Centre is finalising a contract with vaccine manufacturers for procurement of doses. The government, which will make bulk purchases, has also negotiated a better price — almost half that of the likely MRP of Rs 500-600 for the two-shot vaccine, an official source said.

Bharat Biotech’s Covaxin can be considered for emergency approval after it submits data from phase I and II trials. Regulatory sources told TOI that Bharat Biotech is in the process of publishing data for the vaccine which is now in phase 3 trials in India. So, two vaccines could be available by February.

“If everything goes as per plan and the company (SII) manages to secure emergency authorisation in December, we are expecting the first lot of vaccines by January-February and the first set of beneficiaries has been identified,” the official said.

While an estimated 50-60 crore doses will be required to inoculate 25-30 crore priority population categorised into four different groups, initially limited stocks are expected by January-end that will be administered mainly to some of the estimated 70 lakh healthcare professionals and over 2 crore frontline workers including police, municipal workers and armed forces.

The SII has almost completed its phase 3 trials in India and a follow-up of the data is likely to start soon.

“If Serum Institute submits its efficacy data from UK and applies for emergency authorisation here, it can easily be granted. But even in case of Bharat Biotech, if the company applies for emergency use approval after its data from phase 1 and 2 are published, the regulator can consider the same,” the official said, indicating that by February-March, more than one vaccine is likely to get at least emergency use authorisation provided the regulator finds data generated from clinical trials satisfactory.

Meanwhile, government is framing terms of references for two major bodies dealing with vaccine introduction — the National Technical Advisory Group on Immunisation and the Central Drug Standards and Control Organisation — to look into grant of emergency authorisation.

Continue Reading

Health

Renowned cardiologist Dr Bansal opens SSB Heart and Multispecialty Hospital in Faridabad

SSB Heart and Multispecialty Hospital which was formally known as ORG Central Hospital near Neelam Flyover, Sector 20A, Faridabad (Delhi-NCR).

Published

on

SSB Heart Dr Bansal

Renowned cardiologist Dr. S.S. Bansal opens SSB Heart and Multispecialty Hospital in Faridabad.

NCR patients requiring heart monitoring and diagnostics can now have a sign of relief as Renowned cardiologist Dr. S.S. Bansal has opened his own hospital.

Dr. Bansal and his entire expert team including Sr. Heart Surgeon, Dr. Sudeep Singh Sidhu has stared the new hospital in the name of SSB Heart and Multispecialty Hospital which was formally known as ORG Central Hospital near Neelam Flyover, Sector 20A, Faridabad (Delhi-NCR).

Dr. Bansal and his whole team including Sr. Heart Surgeon, Dr. Sundeep Sidhu has moved from Metro Hospital Faridabad.

For appointment of Dr. SS Bansal and Dr. Sudeep Singh Sidhu, please contact Mr. Nishant at +91-7669990182.

SSB Heart Dr Bansal Faridabad
Continue Reading
Advertisement

Most Popular

Corona Virus (COVID-19) Live Data

COVID-19 affects different people in different ways. Most infected people will develop mild to moderate illness and recover without hospitalization.